What's new

Human medicines European public assessment report (EPAR): Prevymis, letermovir, Date of authorisation: 08/01/2018, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Prevymis, letermovir, Date of authorisation: 08/01/2018, Revision: 17, Status: Authorised

Apr 16, 2025 - 12:49
 0
Human medicines European public assessment report (EPAR): Prevymis, letermovir, Date of authorisation: 08/01/2018, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Prevymis, letermovir, Date of authorisation: 08/01/2018, Revision: 17, Status: Authorised
Read More

Tags:

Previous Article

Lyft to buy taxi app Free Now for $200 million to expand into Europe

Next Article

EMA Agile governance model

Related Posts

Orphan designation: Magrolimab Treatment of acute myeloid leukaemia, 11/11/2015 Withdrawn

Orphan designation: Magrolimab Treatment of acute myelo...

Mar 12, 2025  0

EMEA-000205-PIP02-11-M06

EMEA-000205-PIP02-11-M06

Mar 13, 2025  0

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 26, 2025  0